Performance of the CHARGE-AF risk model for incident atrial fibrillation in the EPIC Norfolk cohort

European Journal of Preventive Cardiology

Volumn 22, Issue 7, 2015, Pages 932-939

  Pfister, Roman ^a   Brägelmann, Johannes ^a   Michels, Guido ^a   Wareham, Nick J ^b   Luben, Robert ^c   Khaw, Kay Tee ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atrial fibrillation; risk prediction; score

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIVITAMIN K; DIGITALIS; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; LIFESTYLE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF REPORT; TASK PERFORMANCE; ADVERSE EFFECTS; AGE; CAUCASIAN; CHI SQUARE DISTRIBUTION; COMORBIDITY; DISCRIMINANT ANALYSIS; ENGLAND; ETHNOLOGY; HEALTH STATUS; HEALTH STATUS INDICATOR; KAPLAN MEIER METHOD; MIDDLE AGED; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SMOKING; TIME FACTOR; VALIDATION STUDY;

ADULT; AGE FACTORS; AGED; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DISCRIMINANT ANALYSIS; ENGLAND; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 84930609152     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314544045     Document Type: Article

References (30)

1. Wilke T, Groth A, Mueller S, et al. Incidence and prevalence of atrial fibrillation: An analysis based on 8.3 million patients. Europace. 2013 ; 15: 486-493
2. Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013 ; 34: 2746-2751
3. Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study. Stroke. 2005 ; 36: 1115-1119
4. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation. 2003 ; 107: 2920-2925
5. Miyasaka Y, Barnes ME, Bailey KR, et al. Mortality trends in patients diagnosed with first atrial fibrillation: A 21-year community-based study. J Am Coll Cardiol. 2007 ; 49: 986-992
6. Chamberlain AM, Agarwal SK, Folsom AR, et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol. 2011 ; 107: 85-91
7. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): A community-based cohort study. Lancet. 2009 ; 373: 739-745
8. Alonso A, Krijthe BP, Aspelund T, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: The CHARGE-AF consortium. J Am Heart Assoc. 2013 ; 2: e000102 - e000102
9. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: Study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer. 1999 ; 80: 95-103
10. Pfister R, Sharp SJ, Luben R, et al. Plasma vitamin C predicts incident heart failure in men and women in European Prospective Investigation into Cancer and Nutrition-Norfolk prospective study. Am Heart J. 2011 ; 162: 246-253
11. Lip GY, Golding DJ, Nazir M, et al. A survey of atrial fibrillation in general practice: The West Birmingham Atrial Fibrillation Project. Br J Gen Pract. 1997 ; 47: 285-289
12. Sudlow M, Rodgers H, Kenny RA, et al. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ. 1997 ; 314: 1529-1530
13. Pell JP, McIver B, Stuart P, et al. Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic. Br J Gen Pract. 1993 ; 43: 152-154
14. Saunders KB, Amerasinghe A, Saunders KL. Dose of digoxin prescribed in the UK compared with France and the USA. Lancet. 1997 ; 349: 833-836
15. Pencina MJ, D'Agostino Sr, D'Agostino Jr, et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Statist Med. 2007 ; 27: 157-172
16. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004 ; 23: 2109-2123
17. D'Agostino R, Nam BH Handbook of statistics. Balakrishnan N Rao CR, ed. Amsterdam: Elsevier ; 2004: 1-25.
18. D'Agostino Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores. JAMA. 2001 ; 286: 180-187
19. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, http://www.R-project.org/ (2011, accessed 10 December 2013).
20. Eichler K, Puhan MA, Steurer J, et al. Prediction of first coronary events with the Framingham score: A systematic review. Am Heart J. 2007 ; 153: 722-731.e8
21. Authors/Task Force Members, McMurray JJV, Adamopoulos S, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: Addenda Web Tables - The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847.
22. Authors/Task Force Members, Ryden L, Grant PJ, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on Diabetes, Pre-diabetes, and Cardiovascular Diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34: 3035-3087.
23. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 ; 31: 1281-1357
24. Moyer VA. Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 ; 157: 512-518
25. Bang CN, Gislason GH, Greve AM, et al. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: A nationwide propensity score-matched study. Eur J Prev Cardiol. 2014 ; 21: 330-338
26. Virtanen R, Kryssi V, Vasankari T, et al. Self-detection of atrial fibrillation in an aged population - the LietoAF Study. Eur J Prev Cardiol. Epub ahead of print 18 June 2013. DOI: 10.1177/2047487313494041.
27. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006 ; 355: 251-259
28. Jensen PN, Johnson K, Floyd J, et al. A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf. 2012 ; 21: 141-147
29. Stewart S, MacIntyre K, MacLeod MM, et al. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. Eur Heart J. 2001 ; 22: 693-701
30. Alonso A, Agarwal SK, Soliman EZ, et al. Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009 ; 158: 111-117